New insights into the management of homozygous familial hypercholesterolemia patients treated with lomitapide: a single-center experience
Familial hypercholesterolemia (FH) is a genetic disease, usually with onset during childhood, characterized by elevated blood LDL cholesterol levels and potentially associated with severe cardiovascular complications. Concerning mutated genes in FH, such as LDLR, a small subset of FH patients presen...
Saved in:
| Main Authors: | Gabriella Iannuzzo, Ilenia Lorenza Calcaterra, Marco Gentile, Claudia Stanzione, Francesca de Ruberto, Maria Donata di Taranto, Giovanna Cardiero, Giuliana Fortunato, Matteo Di Minno |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-12-01
|
| Series: | Frontiers in Endocrinology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2024.1515846/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A qualitative study of perceptions of the care pathway for familial hypercholesterolemia: screening, diagnosis, treatment, and family cascade screening
by: Amy R. Pettit, et al.
Published: (2024-12-01) -
The effectiveness of liver transplantation in reducing lipid levels in Saudi children with homozygous familial hypercholesterolemia
by: Abdullah Al-Ashwal, et al.
Published: (2024-11-01) -
Liver transplantation for homozygous familial hypercholesterolemia: a retrospective analysis from Chinese experience
by: Hao-Su Zhan, et al.
Published: (2025-01-01) -
Monacolin K in the treatment of hypercholesterolemia - chance or threat?
by: Katarzyna Krotowska
Published: (2024-12-01) -
Safety and Effectiveness of Low‐Density Lipoprotein Cholesterol–Lowering Therapy With Evolocumab for Familial Hypercholesterolemia/Hypercholesterolemia in Japan: A Real‐World, Postmarketing, Single‐Arm Study
by: Koutaro Yokote, et al.
Published: (2024-11-01)